DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Rydzewska LHM, Burdett S, Vale CL. et al.
Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis.
European journal of cancer (Oxford, England : 1990) 2017;
84: 88-101
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.